Transcription factor NFκB expression and postsurgical organ dysfunction

Annals of Surgery

Volumn 233, Issue 1, 2001, Pages 70-78

  Foulds, Sharmila ^a,c   Galustian, Christine ^a   Mansfield, Averil O ^a   Schachter, Michael ^b  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; GLUTATHIONE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; MULTIPLE ORGAN FAILURE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SEPSIS; SIGNAL TRANSDUCTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; AORTIC ANEURYSM, ABDOMINAL; FEMALE; FLOW CYTOMETRY; GLUTATHIONE; HUMANS; LINEAR MODELS; MACROPHAGE-1 ANTIGEN; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; NF-KAPPA B;

EID: 0035159748     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-200101000-00012     Document Type: Article

References (54)

1. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
2. Multiple organ failure. Pathophysiology and potential future therapy
3. Shock and multiple organ failure
4. Multiple organ failure: A common problem in surgical intensive care unit patients
5. Evolving concepts in the pathogenesis of postinjury multiple organ failure
6. MODS/SIRS: Result of an overwhelming inflammatory response?
7. Multiple organ failure. Pathophysiology and potential future therapy
8. Functional inactivation of neutrophils with a Mac-1 (CD11b/CD18) monoclonal antibody protects againts ischemia-reperfusion injury in rat liver
9. Evolving strategies in the treatment of sepsis and systematic inflammatory response syndrome (SIRS)
10. Neutrophil receptors and modulation of the immune response
11. Recombinant human interleukin-1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial
12. Efficacy and safety of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multi-center clinical trial
13. Treatment of gram negative bacteremia and septic shock with HA-IA human monoclonal antibody againts endoloxin. A randomized, double-blind, placebo-controlled trial
14. Anti-endotoxin monoclonal antibodies
15. The role of nuclear factor kappa B in cytokine regulation
16. Synergy and specificity in induction of gene activity by proinflammatory cytokines: Potential therapeutic targets
17. 2 integrin in vivo
18. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers
19. Lipopolysaccharide signal transduction, regulation of tumor necrosis factor biosynthesis, and signalling by tumor necrosis factor itself
20. Hypoxia causes the activation of nuclear factor kappa B through the phosphorylation of I kappa B alpha on tyrosine residues
21. Free radicals and the xanthine oxidase pathway
22. Nuclear factor-kappa B interacts functionally with the platelet-derived growth factor B-chain shear-stress response element in vascular endothelial cells exposed to fluid shear stress
23. NF-κB and Rel proteins in innate immunity
24. Function and activation of NF-κB in the immune system
25. Regulation of the transcription factors NF-kappa B and AP-I by redox changes
26. Separation of oxidant-initiated and redox-regulated steps in the NF-kappa B signal transduction pathway
27. Effects of anti-nuclear factor κB reagents in blocking adhesion of human cancer cells to vascular endothelial cells
28. Dithiocarbamates as potent inhibitors of nuclear factor-kappa B activation in intact cells
29. Nuclear factor-kappa B
30. Nuclear factor kappa B is activated in macrophages and epithelial cells of inflamed intestinal mucosa
31. Role of NF kappa B in the mortality of sepsis
32. Novel flow cytometric method for quantifying nuclear binding of the transcription factor nuclear factor kappa B in unseparated human monocytes and polymorphonuclear cells
33. Endotoxin-related early neutrophil activation is associated with outcome after thoracoabdominal aortic aneurysm repair
34. Visceral ischemia and neutrophil activation in sepsis and organ dysfunction
35. Thoraco-abdominal and proximal aortic replacement for extensive aortic aneurysmal disease
36. Flow cytometric determination of glutathione alterations in vital cells by O-phtaldialdehyde (OPT) staining
37. Inhibitation of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear translocation sequence
38. The intestinal factor in multiple organ failure and shock
39. Systemic consequences of reperfusion
40. Polymorphonuclear lenkocyte activation. An early marker of the postsurgical sepsis response
41. Neutrophil priming: The cellular signals that say "amber" but not "green."
42. Differantial activation of mixed venous and arterial neutrophils in patients with sepsis syndrome and acute lung injury
43. Enchanced attachment and elastase-releasing capacity of neutrophils after surgery
44. Postinjury neutrophil priming and activation: An early vulnerable window
45. Reperfused gut elaborates PAF that chemoattracts and primes neutrophils
46. Surgery and the release of a neutrophil Fcg receptor
47. Neutrophil priming and activation in the pathogenesis of postinjury multiple organ failure
48. Human toxic neutrophils. 3. Metabolic characteristics
49. Altered neutrophil migration during bacterial infection associated with a serum modulator of cellular motility
50. Heterogeneity in the circulating neutrophil pool: Studies on subpopulations separated by continuous flow electrophoresis
51. Polymorphonuclear cell-mediated vascular injury in anergic surgical patients
52. Activation state of polymorphonuclear leukocytes in surgical patients: Characterization of surface receptor expression
53. Fc gamma receptor III on human neutrophils. Allelic variants have functionally distinct capacities
54. Neutrophil apoptosis is associated with a reduction in CD16 (Fc gamma RIII) expression